What West Pharmaceutical Services does

West Pharmaceutical Services, Inc. (NYSE: WST) is a global manufacturer of containment and delivery solutions for injectable medicines, founded in 1923 and headquartered in Exton, Pennsylvania. The company designs, develops, and produces proprietary elastomer and polymer-based packaging components—including stoppers, seals, prefilled syringe and cartridge components, polymer vials (Daikyo Crystal Zenith), and self-injection devices (SmartDose wearable injectors)—as well as quality enhancement offerings such as FluroTec barrier films and the Envision automated vision inspection process. Underlying the portfolio is a shared elastomer formulation and quality-by-design technology platform that supports both standalone components and integrated systems like the West Synchrony Prefillable Syringe and Ready Pack.

West serves pharmaceutical manufacturers, biotechnology companies, generic drug makers, medical device firms, and contract manufacturing organizations across more than 50 sites in North America, Europe, Asia Pacific, and the Middle East, shipping approximately 41 billion components and devices annually. Revenue is generated primarily through direct enterprise sales of proprietary hardware components (Proprietary Packaging Containment Products) and through contract manufacturing services operated under the West Vantage brand, which provides design, analytical, drug handling, assembly, packaging, regulatory, and fill-finish support. Pricing is quote-based for enterprise customers, supplemented by an online store for small-pack purchases of ready-to-use products. FY2025 net sales reached $3.07 billion, with Q1 2026 revenue of $844.9 million up 21% year-over-year and FY2026 guidance raised to $3.295–$3.350 billion.

Name

West Pharmaceutical Services

Legal name

West Pharmaceutical Services, Inc.

Website

https://westpharma.com

Company type

Public

Founded year

1923

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

West Pharmaceutical Services manufactures containment and delivery systems for injectable medicines—including stoppers, seals, prefilled syringes, polymer vials, and wearable injectors—for global pharmaceutical and biotechnology drug developers across 50 sites worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical packaging components and injectable drug delivery

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (3391), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)

akta.pro secondary industries

Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH), Cold Chain & Temperature-Controlled Packaging (Insulated Shippers, Gel Packs) (IMALAIAG), Rigid Pharmaceutical & Healthcare Plastic Packaging (Pill Bottles, Vials, Med-Grade Jars) (IMALAAAE), Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)

Keywords

• Injectable drug packaging
• Pharmaceutical containment components
• Elastomer stoppers seals
• Prefillable syringe systems
• Self-injection delivery devices

Headquarters

HQ city

Exton

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Proprietary Packaging Containment Products: Manufacture and sale of proprietary packaging components including stoppers and seals for injectable packaging systems, syringe and cartridge components, self-injection devices, and containment solutions. Revenue from high-value product components showed 29.6% growth in Q1 2026, with GLP-1 elastomers representing 10% of total company revenue.
2. Contract Manufacturing Services: Injection molding, contract assembly, and finished packaging services from eight locations in North America and Europe. Services include design and development engineering, analytical testing, drug handling, assembly, packaging, regulatory support, and fill-finish enablement. Operated under West Vantage brand.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

West Pharmaceutical Services manufactures and sells integrated containment and delivery solutions for injectable medicines, including proprietary elastomer components (stoppers, seals, plungers), Daikyo Crystal Zenith polymer vials, prefillable syringe systems (including the West Synchrony platform), cartridge components, wearable on-body self-injection devices (SmartDose), quality enhancement films and coatings (FluroTec, Envision, Westar wash), and bundled Ready Pack configurations. The company also offers West Vantage contract manufacturing and fill-finish support services covering design engineering, analytical testing, drug handling, assembly, and packaging.

Product overview

West Pharmaceutical Services is a leading provider of integrated containment and delivery solutions for injectable medicines. The company operates as a platform of interconnected product lines serving pharmaceutical and biotech customers: its core proprietary products include vial containment solutions (stoppers, seals, Daikyo Crystal Zenith polymer vials), prefillable syringes (including the West Synchrony system), cartridge components, and self-injection devices (SmartDose on-body delivery platform in 3.5mL and 10mL variants). These are complemented by quality enhancement offerings (FluroTec barrier films, Envision vision inspection, Westar wash processes) and sub-branded component tiers (NovaPure premium, Westar Select, AccelTRA for generics). The portfolio is unified by shared elastomer technology platforms and quality standards, allowing customers to source integrated packaging systems (Ready Pack) or engage West Vantage contract manufacturing services for end-to-end development through commercialization. Products are designed for biologics, vaccines, and chronic disease therapies including GLP-1 treatments.

Differentiator

Problem solved

Functional benefit

Brands

• Daikyo Crystal Zenith: High-performance polymer vials and containment solutions for biologics, licensed technology from Daikyo Seiko, Ltd.
• NovaPure
• Westar
• SmartDose
• West Synchrony
• FluroTec
• Envision

Products and services

• Vial Containment Solutions Stoppers, seals, and components for injectable packaging systems that help ensure drug compatibility and stability while supporting operational efficiency. Used by pharmaceutical manufacturers packaging injectable therapies.
• Daikyo Crystal Zenith Cyclic Olefin Polymer Vials High-performance cyclic olefin polymer alternative to glass that meets the challenges of sensitive biologics. Polymer vials and components for injectable packaging, licensed from Daikyo Seiko, Ltd., offering superior drug compatibility and stability.
• Prefillable Syringes Comprehensive syringe components including custom solutions for the specific needs of injectable drug applications, including custom configurations and materials for pharmaceutical drug developers.
• West Synchrony Prefillable Syringe System Integrated prefillable syringe system designed to reduce development timelines and regulatory complexity for drug developers by providing a verified syringe set from a single supplier with comprehensive documentation support. Offers over 200 validated configurations and is commercially manufactured at the Waterford, Ireland facility.
• Self-Injection Devices Innovative, patient-centric self-injection technologies that are easy to use and can be combined with connected health technologies to increase patient adherence. Targeted at pharmaceutical and biotech manufacturers developing subcutaneous injectable therapies.
• SmartDose On-Body Delivery System (OBDS) Battery-powered wearable injector platform enabling subcutaneous self-administration of large-volume drug formulations. Includes SmartDose 3.5 (up to 3.5 mL) and SmartDose 10 (up to 10 mL) models. Used by partners including Amgen and Roche.
• Cartridge Components Components for multi-use pen or injectors including cartridge plungers and seals with tight dimensional tolerances suitable for high-viscosity drugs and various storage conditions. Used in devices for chronic disease and self-administration therapies.
• Vial Transfer Devices Drug reconstitution and transfer devices for safe handling and administration of injectable medicines, supporting healthcare providers and patients with safe injectable handling workflows.
• NovaPure Components Premium line of elastomer components designed according to Quality-by-Design principles, featuring FluroTec barrier film, tighter dimensional control, and Envision vision inspection for the highest quality standards for vials, stoppers, syringes, and plungers.
• Westar Select Components High-quality line of pharmaceutical wash and sterilized products with defined Global Product Portfolio focused on component capability, tighter visible particulate specification, and enhanced AQL program for stoppers and related components.
• AccelTRA Components Program Components program developed to help generic drug manufacturers meet increasing quality standards, facilitate fast response to market variability, and standardize around a next generation formulation at competitive pricing.
• Ready Pack System Pre-configured packaging system combining Daikyo Crystal Zenith vial, NovaPure stopper, and Flip-Off CCS seal. Available in small quantities for rapid scale-up and clinical trials; proven at -80°C storage with container closure integrity for first FDA-approved gene therapy for pediatric Spinal Muscular Atrophy.
• FluroTec Barrier Film Fluoro-polymer barrier film coating technology for elastomer components that protects biologics by providing superior barrier properties against moisture and gas transmission, licensed from Daikyo Seiko, Ltd.
• Envision Automated Vision Inspection Automated vision inspection process that enhances quality of washed or sterilized components, mitigating risk of foreign matter and selecting for customer-specified attributes or AQLs across packaging components.
• Westar Wash Process Washing process for pharmaceutical components providing documented validation across all aspects including process equipment, laboratory equipment, test methods, and packaging. Results reported in quality certificates for ready-to-sterilize components.
• Westar RU and RS Lined Seals Laminate technology with bilayer seal design for cartridge components ensuring industry-leading specifications for resealability, reduced fragmentation, and minimal contribution of particles. Available in ready-to-use and ready-to-sterilize formats.
• West Vantage Contract Manufacturing Services Single-source contract manufacturing services from product conceptualization through manufacturing and final packaging. Includes design engineering, analytical testing, drug handling, assembly, packaging, regulatory support, and fill-finish enablement. Operated from eight locations in North America and Europe.
• Fill-Finish Support Services Services including sample preparation for product testing, fill-finish implementation consulting, clinical and commercial filling collaborations, analytical testing, and program management to support injectable drug development and commercialization.

Quantifiable outcome

• 21% year-over-year revenue growth in Q1 2026
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered core and minor.

• AbbViecoreStrategic or Co-development Partner · 1 April 2026West agreed to sell SmartDose 3.5mL On Body Delivery System manufacturing rights to AbbVie for $112.5 million. This represents a strategic shift toward higher-margin, lower capital intensity operations for West.
• CorningcoreTechnology or IntegrationWest collaborates with Corning to enable new, advanced pharmaceutical packaging solutions. The collaboration optimizes the materials science and manufacturing expertise of both companies to help bio-pharma producers navigate the complex regulatory environment and mitigate risk in bringing drugs to market.
• Latch MedicalcoreStrategic or Co-development PartnerWest made a strategic investment with Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology pioneering a new approach to intradermal delivery.
• TECHIN (Technology Innovation Foundation of IIT Palakkad)minorStrategic or Co-development PartnerTECHIN combines West's medical expertise with IIT's unique incubation model to advance research and development in medical technology.
• EIT Health Ireland-UKminorStrategic or Co-development PartnerWest joined EIT Health Ireland-UK as newest partner and member of Europe's largest health innovation network, comprising 280 world-class organizations across business, research, education, and health service delivery.
• MEDX XeleratorminorStrategic or Co-development PartnerWest and MEDX Xelerator, an Israeli-based medical device incubator, signed a collaboration agreement focused on identifying and developing early-stage medical technology innovation.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Gerresheimer AG: German-headquartered manufacturer of primary pharmaceutical packaging (glass vials, ampoules, syringes, plastic containers) and drug delivery devices. Closest publicly listed peer to West's vial containment, prefillable syringe, and elastomer component lines, competing head-to-head for injectable packaging contracts with the same pharma customers.
• Schott AG: Private German manufacturer of pharmaceutical glass vials, ampoules, syringes (Schott TOPAC), and polymer alternatives. Directly comparable to West's Daikyo Crystal Zenith polymer vials and traditional glass containment offerings, supplying the same biologic and vaccine customers with primary injectable packaging.
• Stevanato Group: Italian producer of pharmaceutical glass containers (vials, syringes, cartridges) and integrated drug delivery systems including the Nexa and SG Human platforms. Directly comparable to West in prefillable syringes, vial containment, and wearable injector platforms, competing on the same biologic, GLP-1, and vaccine opportunities.
• Datwyler Holding: Swiss-listed manufacturer of elastomer components for pharmaceutical packaging (stoppers, seals, plungers) — the closest direct competitor to West's core elastomer franchise including Westar, NovaPure, and FluroTec product lines serving injectable drug manufacturers globally.
• AptarGroup: U.S.-listed provider of drug delivery systems including prefilled syringes, auto-injectors, on-body injectors, and nasal/inhalation platforms via its Aptar Pharma segment. Directly comparable to West's SmartDose on-body delivery and self-injection platforms, competing for the same large-volume injectable and combination product opportunities.

Broad incumbents

• Becton Dickinson (BD): Large-cap medical device and life sciences company whose BDX segment includes prefillable syringes (BD Hypak, BD Neopak), autoinjectors, and pharmaceutical systems. Broad incumbent with overlapping injectable containment and drug delivery portfolio but operating across a much wider medtech and diagnostics business.
• Catalent: Major CDMO providing fill-finish and packaging services for injectable therapies. Direct comparator to West Vantage contract manufacturing services and fill-finish enablement offerings, serving the same biologic and gene therapy customers with end-to-end manufacturing and packaging.
• Thermo Fisher Scientific: Global life sciences tools and services company with a sizable pharma services business (including Patheon CDMO). Relevant both as incoming CEO Michel Lagarde's prior employer and as a broad incumbent providing fill-finish, packaging, and analytical services overlapping with West Vantage.
• AMCOR: Global packaging company with a Healthcare segment producing plastic and specialty packaging for pharma and medical devices. Adjacent incumbent serving pharmaceutical customers with primary packaging components, though with broader consumer packaging exposure and less specialization in injectable elastomer systems.

Emerging players

• West Pharmaceutical Services' partner/license rival — Daikyo Seiko: Japanese primary packaging components manufacturer and current licensor of Daikyo Crystal Zenith polymer vials and FluroTec barrier film to West. Functions as both a licensor and an emerging competitor in polymer-based injectable containment in Asia, especially relevant as biologics manufacturing localizes in the region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/WestPharma
• Facebookfacebook.com/WestPharma
• LinkedInlinkedin.com/company/west-pharmaceutical-services

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about West Pharmaceutical Services